Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease
US12060353B2 · kind B2 · utility
1Cited by
1References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2023 |
| Grant date | Aug 13, 2024 |
| Priority date | — |
| Expiry date | Nov 2, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, compositions and their use in the treatment of a proliferative disease or condition such as a said proliferative disease or disorder is associated with a RAF gene mutation and/or a RAS gene mutation. The compounds disclosed are of Formula I or a pharmaceutically acceptable salt or solvate thereof, wherein R1, R2, R3, X1, X2, X3 and X4 are as defined herein:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.